BlackRock Institutional Trust’s Genomic Health, Inc. GHDX Stock Holding History

BlackRock Institutional Trust’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$20.6M	Buy	699,415 +51,769	+8%	+$1.58M	﹤0.01%	1944
2016 Q3	$18.7M	Buy	647,646 +63,904	+11%	+$1.78M	﹤0.01%	1943
2016 Q2	$15.1M	Buy	583,742 +55,629	+11%	+$1.48M	﹤0.01%	2028
2016 Q1	$13.1M	Sell	528,113 -34,121	-6%	-$936K	﹤0.01%	2103
2015 Q4	$19.8M	Sell	562,234 -25,693	-4%	-$688K	﹤0.01%	1874
2015 Q3	$12.4M	Sell	587,927 -39,601	-6%	-$1.02M	﹤0.01%	2141
2015 Q2	$17.4M	Buy	627,528 +70,350	+13%	+$1.98M	﹤0.01%	2019
2015 Q1	$17M	Buy	557,178 +64	+0%	+$2.04K	﹤0.01%	2052
2014 Q4	$17.8M	Buy	557,114 +2,973	+0.5%	+$96.8K	﹤0.01%	1984
2014 Q3	$15.7M	Sell	554,141 -8,195	-1%	-$228K	﹤0.01%	2035
2014 Q2	$15.4M	Sell	562,336 -3,419	-0.6%	-$91K	﹤0.01%	2141
2014 Q1	$14.9M	Buy	565,755 +23,515	+4%	+$675K	﹤0.01%	2158
2013 Q4	$15.9M	Buy	542,240 +31,876	+6%	+$1.01M	﹤0.01%	2112
2013 Q3	$15.6M	Sell	510,364 -10,653	-2%	-$356K	﹤0.01%	2042
2013 Q2	$16.5M	Buy	+521,017	New	+$17.1M	﹤0.01%	1956

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

BlackRock Institutional Trust's GHDX Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Genomic Health, Inc. (GHDX) stake by 8% in Q4 2016, buying an estimated $1.58M and bringing the position to 699,415 shares worth $20.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1944.

BlackRock Institutional Trust first reported a position in GHDX in Q2 2013 and has held it in 15 quarters since. 133 funds tracked by Wall St. Rank hold GHDX as of Q4 2016.

BlackRock Institutional Trust held 699,415 shares of Genomic Health, Inc. worth $20.6M as of Q4 2016.
BlackRock Institutional Trust bought 51,769 Genomic Health, Inc. shares in Q4 2016, an estimated $1.58M.
Genomic Health, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1944 holding.
BlackRock Institutional Trust first reported a position in Genomic Health, Inc. in Q2 2013 and has held it in 15 quarters since.
133 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.